| Overview |
| bsm-52170r |
| IRF3(S386) (28C3) Monoclonal Antibody |
| WB, ICC/IF |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| Synthetic peptide derived from human IRF3(S386), around 350-400aa (phospho S386). |
| S386 |
| Monoclonal |
| 28C3 |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C for 12 months. |
| Target |
| 3661 |
| Q14653 |
| Bone Morphogenic Protein 6; Decapentaplegic vegetal related; DVR6; BMP 6; BMP-6; TGFB related vegetal related growth factor; Transforming growth factor beta; Vegetal related TGFB related cytokine; Vg related sequence; VGR1; BMP6_HUMAN. |
| The bone morphogenetic proteins (BMPs) are a family of secreted signaling molecules that can induce ectopic bone growth. Many BMPs are part of the transforming growth factor-beta (TGFB) superfamily. BMPs were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. Based on its expression early in embryogenesis, the BMP encoded by this gene has a proposed role in early development. In addition, the fact that this BMP is closely related to BMP5 and BMP7 has lead to speculation of possible bone inductive activity. [provided by RefSeq]. |
| Application Dilution |
| WB |
1:500-1000 |
| ICC/IF |
1:50-100 |
Powered by Bioz